European Medicines Agency (EMEA)
EPARs:
- Acrescent, memantine hydrochloride / donepezil hydrochloride, Revision: 0, Refused
- Balaxur, memantine hydrochloride / donepezil hydrochloride, Revision: 0, Refused
- Yentreve, Duloxetine, Revision: 17, Authorised
- Xeristar, Duloxetine, Revision: 20, Authorised
- Cymbalta, Duloxetine, Revision: 18, Authorised
- Ariclaim, Duloxetine, Revision: 20, Authorised
- Olanzapine Teva, Olanzapine, Revision: 10, Authorised
- Nemdatine, Memantine, Revision: 0, Authorised
- Memantine Mylan, Memantine, Revision: 0, Authorised
- Memantine Mylan, Memantine, Revision: 0, Authorised
- Valdoxan, Agomelatine, Revision: 9, Authorised
Other:
- Withdrawn application: Memantine FGK, Initial authorisation (updated)
- Pending EC decision: Memantine ratiopharm, memantine hydrochloride
Press Releases:
- European Medicines Agency publishes final advice from clinical trial advisory groups
- European Medicines Agency receives interim decisions of the General Court of the EU on access to clinical and non-clinical information
- European Medicines Agency workshop on multiplicity issues in clinical trials
|